We’re pleased to announce that the Medical Data Science team is growing in Finland, as Tuomas Kovalainen joins the team.Tuomas is a genuinely nice, and…
MedEngine Oy announced today that Saku Torvinen, PhD, joins MedEngine Oy as Director of Market Access. At MedEngine, he will be responsible for the launch…
MedEngine Oy announced today that it has acquired the Institute of Applied Economics and Health Research ApS (ApHER), a leading Danish medical data science company.…
Finnish Haemophilia patients have comprehensive followup and most receive factor replacement therapy, shows the results from the HemoHEOR study which was published this week in…
Obesity has a significant negative impact on quality of life (QoL) and perceived physical and psychological working ability. This summarizes the first results of the…
Haemophilia treatment in Finnish university hospitals is of excellent quality and at costs reasonable within European standards, shows the HemoHEOR study conducted by MedEngine that…